1) Product Name:Supply Nootropic aniracetam/Unifiram/Sunifiram/Prl-8-53 powder
2) Purity:99%
3) Testing Method:HPLC
4) Appearance:White crystalline powder
5) Introduction:
Aniracetam
(1-[(4-methoxybenzoyl)">- 2-pyrrolidinone) is a fat soluble analog
of the nootropic Piracetam. While it shares many of Piracetam’s effects
on the brain it has two main unique advantages Piracetam does not have:
1. Being fat soluble, Aniracetam it has far better penetration into the
brain through the blood brain barrier. 2. Aniracetam is a potent
stimulator of the brain’s Glutamate AMPA receptors. AMPA receptor
research is considered an exciting development in studying and enhancing
cognition. Such compounds that effect AMPA receptors are called
Ampakines. The USA's Defense Advanced Research Projects Agency (DARPA)
has been actively researching ampakines for military use.
Unifiram
(DM232) is another recent entrant in the Racetam family which is
structurally similar to an ampakine and is closely related to Sunifiram
(DM235), with the first studies on the drug being published in 2003.
More studies need to be conducted to fully elucidate theeffects of
Unifiram, but it appears to be effective as a Nootropic and as an
anti-amnesic.
In the studies conducted, Unifiram was noted to have
three primary benefits: anti-amnesia, acetylcholine agonism, and
anti-sedative and anti-hypnotic effects.
Two of the studies on
Unifiram and its analogs focused on its ability to reverse the amnesic
effects of AMPA antagonists and its precognitive effects utilizing the
Mouse Passive Avoidance test for their experimental methodology.
Another
study noted that Unifiram appears to increase acetylcholine release in
rats; acetylcholine is very strongly correlated to memory and learning.
There was one other study done that found, on top of being an
anti-amnesic, Unifiram reduces the effects of barbiturates especially
the effects of hypnosis and sedation.
